DVx Overview

  • Founded
  • 1986


  • Status
  • Public

  • Employees
  • 342


  • Stock Symbol
  • 3079

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $7.11
  • (As of Wednesday Closing)

DVx General Information


DVx Inc is engaged in manufacture, sale, repair, and leasing of medical equipment and related peripheral equipment, research and development of medical equipment, provide in house and out of service consulting services and services for medical and medical devices, and providing medical publication and market research.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Distributors (Healthcare)
Other Industries
Other Healthcare Services
Stock Exchange
Primary Office
  • Mejiro Nakano Building
  • 5F 2-17-22 Takada, Toshima-ku
  • Tokyo, Toshima-ku 171-0033
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DVx Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.11 $7.12 $5.54 - $8.24 $74M 10.4M 37K $0.64

DVx Financials Summary

In Thousands,
TTM 30-Jun-2023 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021
EV 300 13,102 24,877 44,507
Revenue 344,627 350,740 404,976 386,714
EBITDA 12,858 14,463 11,613
Net Income 6,687 6,915 7,682 5,398
Total Assets 157,095 177,040 181,984 186,450
Total Debt 0 77 0 15
Public Fundamental Data provided by Morningstar, Inc. disclaimer

DVx Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DVx‘s full profile, request access.

Request a free trial

DVx Patents

DVx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021115220-A Catheter and fixing tool of guide wire Pending 24-Jan-2020
AU-2021210280-A1 Contrast medium injection device and injection line kit Pending 20-Jan-2020 000000000
CA-3164400-A1 Contrast medium injection device and injection line kit Pending 20-Jan-2020 000000000
EP-4094786-A1 Contrast medium injection device and injection line kit Pending 20-Jan-2020 000000000
JP-2021112410-A Contrast medium injector and injection line kit Active 20-Jan-2020 A61M5/007 0
To view DVx’s complete patent history, request access »

DVx Executive Team (1)

Name Title Board Seat Contact Info
Hiroshi Shibasaki President & Chief Executive Officer
To view DVx’s complete executive team members history, request access »

DVx Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DVx Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 29-Mar-2021 00000 0000 00.00 Therapeutic Devices
ICorNet 05-Feb-2018 Seed Round 00.000 Therapeutic Devices
To view DVx’s complete investments history, request access »


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies







Medical Distribution




To view DVx’s complete esg history, request access »